📣 📣 AWARDEE ANNOUNCEMENT 📣 📣
The PhRMA Foundation awarded 9 early career researchers a total of $520,000 in 2026 fellowships and grants for their value assessment and health outcomes research.
Learn more: https://t.co/xzVd4TgNc5
Huge thanks to my mentors @EpiHarris and @PharmEpi for the support! Honored to share our work on vaccine timing by the intersection of race, ethnicity, and geography. Excited for the research journey ahead as well!
Congratulations @yalindd on her first first-author paper just published in Vaccine, where rigorously examined the intersection of race and ethnicity, geography, and social deprivation for on-time COVID-19 vaccination! @BrownHSPP https://t.co/phsITHKkQU
Where you live had a lot to do with which COVID-19 vaccine you got.
In over 14 million Medicare beneficiaries, we found really large rural-urban variation in who received Pfizer vs Moderna - out today in @Health_Affairs.
@Brown_SPH@BrownGero
https://t.co/Fi1sgCOygj
"The Promise and Challenges of Dual Vaccination"
My colleagues and I published a study describing COVID-19 and influenza vaccine co-administration among US older adults - large variation and disparities in overall influenza vaccinations were found.
https://t.co/3XFCoE5PAr
Study led by brilliant Dr. @EpiHarris found that co-administration of covid + flu vaccines more than tripled between the 2021 and 2022 flu seasons - can you guess which groups were more or less likely to have these 2 vaccines administered at the same time?
https://t.co/E2oGzhmUGV
Congratulations to Hyunkyung (Yulia) Yun on leading a new @JAMANetworkOpen study: Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.
https://t.co/gtbxTGcWbH
There is a new @NIHAging data resource to conduct #rxepi and aging research – COVVAXAGE! The data source includes over 38M Medicare beneficiaries and their health services use over time (eg inpatient, outpatient, and medication claims). #epitwitter
https://t.co/xJgt0pcA9B